Literature DB >> 31131395

Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.

Claire H Stevens1,2, Natalie J Guthrie1,2, Marloes van Roijen3, Glenda M Halliday4, Lezanne Ooi1,2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is characterized by the progressive degeneration of motor neurons. There is a pathological and genetic link between ALS and frontotemporal lobar degeneration (FTLD). Although FTLD is characterized by abnormal phosphorylated tau deposition, it is unknown whether tau is phosphorylated in ALS motor neurons. Therefore, this study assessed tau epitopes that are commonly phosphorylated in FTLD, including serine 396 (pS396), 214 (pS214), and 404 (pS404) in motor neurons from clinically pure sporadic ALS cases compared with controls. In ALS lower motor neurons, tau pS396 was observed in the nucleus or the nucleus and cytoplasm. In ALS upper motor neurons, tau pS396 was observed in the nucleus, cytoplasm, or both the nucleus and cytoplasm. Tau pS214 and pS404 was observed only in the cytoplasm of upper and lower motor neurons in ALS. The number of motor neurons (per mm2) positive for tau pS396 and pS214, but not pS404, was significantly increased in ALS. Furthermore, there was a significant loss of phosphorylated tau-negative motor neurons in ALS compared with controls. Together, our data identified a complex relationship between motor neurons positive for tau phosphorylated at specific residues and disease duration, suggesting that tau phosphorylation plays a role in ALS.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Motor neuron disease; Motor neurons; Neurodegeneration; Neuropathology; Phosphorylation; Tau

Mesh:

Substances:

Year:  2019        PMID: 31131395      PMCID: PMC7967836          DOI: 10.1093/jnen/nlz041

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  59 in total

1.  The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study.

Authors:  Julie Phukan; Marwa Elamin; Peter Bede; Norah Jordan; Laura Gallagher; Susan Byrne; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-08-11       Impact factor: 10.154

Review 2.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

3.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

Review 4.  Amyotrophic lateral sclerosis: moving towards a new classification system.

Authors:  Ammar Al-Chalabi; Orla Hardiman; Matthew C Kiernan; Adriano Chiò; Benjamin Rix-Brooks; Leonard H van den Berg
Journal:  Lancet Neurol       Date:  2016-10       Impact factor: 44.182

5.  Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.

Authors:  J Götz; F Chen; J van Dorpe; R M Nitsch
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 6.  ALS/FTLD: experimental models and reality.

Authors:  Rachel H Tan; Yazi D Ke; Lars M Ittner; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2017-01-05       Impact factor: 17.088

7.  The Tyr216 phosphorylated form of GSK3β contributes to tau phosphorylation at PHF-1 epitope in response to Aβ in the nucleus of SH-SY5Y cells.

Authors:  Anastasia Noel; Laurence Barrier; Sabrina Ingrand
Journal:  Life Sci       Date:  2016-06-22       Impact factor: 5.037

Review 8.  Tau pathology and neurodegeneration.

Authors:  Maria Grazia Spillantini; Michel Goedert
Journal:  Lancet Neurol       Date:  2013-06       Impact factor: 44.182

Review 9.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

Authors:  Seyedeh Maryam Alavi Naini; Nadia Soussi-Yanicostas
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

10.  Pathologic Thr175 tau phosphorylation in CTE and CTE with ALS.

Authors:  Alexander J Moszczynski; Wendy Strong; Kathy Xu; Ann McKee; Arthur Brown; Michael J Strong
Journal:  Neurology       Date:  2018-01-03       Impact factor: 9.910

View more
  7 in total

Review 1.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

2.  Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis.

Authors:  Tiziana Petrozziello; Evan A Bordt; Alexandra N Mills; Spencer E Kim; Ellen Sapp; Benjamin A Devlin; Abigail A Obeng-Marnu; Sali M K Farhan; Ana C Amaral; Simon Dujardin; Patrick M Dooley; Christopher Henstridge; Derek H Oakley; Andreas Neueder; Bradley T Hyman; Tara L Spires-Jones; Staci D Bilbo; Khashayar Vakili; Merit E Cudkowicz; James D Berry; Marian DiFiglia; M Catarina Silva; Stephen J Haggarty; Ghazaleh Sadri-Vakili
Journal:  Mol Neurobiol       Date:  2021-11-10       Impact factor: 5.682

Review 3.  Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.

Authors:  Yuichi Riku; Danielle Seilhean; Charles Duyckaerts; Susana Boluda; Yohei Iguchi; Shinsuke Ishigaki; Yasushi Iwasaki; Mari Yoshida; Gen Sobue; Masahisa Katsuno
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 4.  Alterations in Tau Metabolism in ALS and ALS-FTSD.

Authors:  Michael J Strong; Neil S Donison; Kathryn Volkening
Journal:  Front Neurol       Date:  2020-11-23       Impact factor: 4.003

5.  Amyotrophic Lateral Sclerosis After Exposure to Manganese from Traditional Medicine Procedures in Kenya.

Authors:  Elin Roos; Sebastian K T S Wärmländer; Jeremy Meyer; Sabrina B Sholts; Jüri Jarvet; Astrid Gräslund; Per M Roos
Journal:  Biol Trace Elem Res       Date:  2020-11-23       Impact factor: 3.738

6.  Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid.

Authors:  Tiziana Petrozziello; Ana C Amaral; Simon Dujardin; Sali M K Farhan; James Chan; Bianca A Trombetta; Pia Kivisäkk; Alexandra N Mills; Evan A Bordt; Spencer E Kim; Patrick M Dooley; Caitlin Commins; Theresa R Connors; Derek H Oakley; Anubrata Ghosal; Teresa Gomez-Isla; Bradley T Hyman; Steven E Arnold; Tara Spires-Jones; Merit E Cudkowicz; James D Berry; Ghazaleh Sadri-Vakili
Journal:  Brain Pathol       Date:  2021-11-14       Impact factor: 6.508

7.  Pathogenic effect of TP73 Gene Variants in People With Amyotrophic Lateral Sclerosis.

Authors:  Kristi L Russell; Jonathan M Downie; Summer B Gibson; Spyridoula Tsetsou; Matthew D Keefe; Jerry A Duran; Karla P Figueroa; Mark B Bromberg; L Charles Murtaugh; Joshua L Bonkowsky; Stefan M Pulst; Lynn B Jorde
Journal:  Neurology       Date:  2021-06-16       Impact factor: 11.800

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.